Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% Given twice daily in patients with glaucoma or ocular hypertension

Research output: Contribution to journalArticlepeer-review

142 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% Given twice daily in patients with glaucoma or ocular hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences